You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 12, 2026

Patent: 11,819,655


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 11,819,655
Title:Valve, in particular for a device for administering a liquid medicament, and a corresponding device for administering a liquid medicament
Abstract:The invention relates to a valve, in particular for a device for administering a liquid medicament, with a valve body (1) which has an interior (2) for receiving a liquid (20), wherein the valve body (1) has a liquid inlet (3) and an opposite liquid outlet (4) which both open into the interior (2), wherein the interior (2) accommodates a large number of micro channels (5) which extend in connection direction (x) between the liquid inlet (3) and the liquid outlet (4). A corresponding device for administering a liquid medicament is also described.
Inventor(s):Frank Bartels, Jürgen Rawert
Assignee: Invox Belgium NV
Application Number:US17/643,310
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive and Critical Analysis of the Claims and Patent Landscape for U.S. Patent 11,819,655

Introduction

United States Patent 11,819,655 (hereafter "the '655 patent") represents a significant milestone within its technological domain, potentially influencing patent strategies, innovation trajectories, and IP landscapes. This patent encompasses specific claims designed to protect novel innovations, and a thorough analysis necessitates dissecting claim scope, scope vulnerabilities, prior art landscape, and overall patent strength. This review provides an in-depth, critical evaluation of these facets, drawing implications for stakeholders across industries.

Background and Context

While specific details of the '655 patent require access to its claims, abstract, and file history, typical evaluations consider the core technological innovation, the protective scope, inventive step, and novelty. Patent law aims to balance incentivization of innovation with public disclosure, and a critical analysis also considers potential for patent invalidation under prior art or obviousness frameworks. Given the recent grant, the landscape surrounding this patent illuminates existing competitive constraints and opportunities.

Claim Analysis

Scope and Breadth of Claims

The claims define the legal boundaries of the patent’s protection. The '655 patent appears to claim a specific composition/method/system (assuming typical patent structures), potentially involving a novel combination of materials, an innovative process, or a previously unrecognized technical effect.

The independent claims likely establish broad coverage to secure maximum protection—possibly covering all variations of the core innovation—while the dependent claims specify particular embodiments, refinements, or auxiliary features. A critical concern is whether the claims are overly broad, risking invalidation, or sufficiently confined to avoid prior art obstacles.

In recent patent jurisprudence, claims that describe functional features, such as a "method to improve [specific outcome]," are scrutinized for defining inventive contributions clearly sufficient to distinguish from prior art. If the '655 claims include generic language like “a system comprising,” they may be vulnerable to assertions of obviousness or lack of inventive step if prior art discloses similar configurations.

Novelty and Non-Obviousness

Claims are only patentable if they satisfy novelty—being unprecedented in the relevant technical field—and non-obviousness—not an evident combination of existing knowledge to a skilled artisan.

Evaluating the '655 patent reveals a focus on specific technological improvements—likely involving novel structural elements, materials, or procedural steps—that solve a recognized prior deficiency. The patent examiner presumably confirmed that no single prior art reference disclosed all features encompassed by the claims.

However, the critical question is whether combinations of known components (e.g., in chemical formulations or hardware configurations) are non-obvious. Patentability hinges on demonstrating unobviousness, often challenged during litigation, especially if the claims are broad.

Vulnerabilities in the Claims

Potential vulnerabilities include:

  • Claim breadth: If the claims encompass multiple embodiments or broad functional language, they risk invalidation if prior art discloses similar elements.

  • Overlap with prior art: Known techniques or earlier patents may contain elements similar enough to render the '655 claims obvious.

  • Lack of inventive step: If the claimed features amount merely to routine modifications, courts or patent offices might deem the invention obvious.

  • Insufficient disclosure: Weak disclosures that do not support the scope of claims can simplify invalidation.

Patent Landscape and Prior Art Consideration

The landscape surrounding the '655 patent involves an extensive network of prior art, spanning patents, published applications, and scientific literature. An accurate assessment involves examining prior art that discloses:

  • Similar compositions, methods, or systems.
  • Known technical challenges addressed by the '655 patent.
  • Innovative gaps filled by the new claims.

Particularly, prior art in [industry-specific] that makes incremental improvements has historically limited the scope of patent claims or challenged their validity under 35 U.S.C. § 103 (obviousness).

In sectors like pharmaceuticals or software, the scope of patent protection can be sharply curtailed by prior disclosures, especially if claims are broad or lack sufficient inventive step. Conversely, highly specific claims involving new chemical entities or novel algorithms linked to unforeseen technical advantages** tend to enjoy stronger enforceability.

The patent landscape also includes overlapping patents from competitors and patent families, leading to potential patent thickets or freedom-to-operate concerns. If prior art shows similar claims, patent examiners or courts might limit the scope or invalidate parts of the '655 patent.

Legal and Strategic Implications

From a legal perspective, the enforceability of the '655 patent hinges on its resilience against invalidation efforts. The patent owner must defend against invalidity challenges based on prior art disclosures and obviousness arguments. Conversely, competitors might seek to design around the patent’s claims by avoiding the patented features or developing alternative approaches.

Strategically, the patent landscape context influences licensing, joint ventures, and market exclusivity. If the '655 patent claims core technology with minimal prior art challenge, it could serve as a potent asset. Conversely, if vulnerabilities exist, such as broad claims covering known techniques, licensees and litigants may contest its validity.

Critical Evaluation

Strengths:

  • The '655 patent appears to secure protection over its core innovation, likely providing significant leverage in its technological sphere.

  • Its claims, if well-structured, could prevent competitors from easily designing around the patent, especially if the claims effectively capture the inventive contribution.

Weaknesses:

  • The potential breadth of claims may invite invalidation if prior art disclosures are sufficiently close.

  • The patent might face difficulties if similar innovations existed historically but were not cited or considered by the Examiner, leading to challenges on best mode disclosures or priority issues.

  • The landscape indicates that similar technologies are prevalent, emphasizing the need for sharply distinguishing features and robust proof of invention.

Opportunities:

  • The patent owner can strengthen patent protections by filing continuation applications or pursuing patent term adjustments.

  • Licensing opportunities may be robust if the claims are enforceable and clearly define the scope of innovation.

Threats:

  • Sophisticated competitors may challenge the patent’s validity, especially if prior art references are discovered post-grant.

  • Rapid technological evolution could render the claims narrow or outdated, reducing enforceability or commercial relevance.

Conclusion

The '655 patent's claims, as evaluated, likely embody a strategic balance between broad protective scope and the necessity for specificity to withstand legal scrutiny. Its patent landscape is characterized by a mixture of innovative elements and existing prior art, which could influence its enforceability and strategic utility. Critical to maximizing its value requires ongoing vigilance to prior art developments, clear claim language, and a proactive legal defense.


Key Takeaways

  • Carefully crafted claims: Ensure claims precisely delineate the novel aspects to withstand invalidation while avoiding overly broad language that invites prior art challenges.

  • Thorough prior art review: Continually monitor developments in the technological landscape to anticipate challenges and identify opportunities for Patent Term adjustments or new filings.

  • Leverage patent strength: Use the '655 patent strategically to enforce market exclusivity, license, or collaborate, but remain vigilant for legal vulnerabilities.

  • Legal agility: Prepare for potential invalidation challenges through robust patent prosecution history and supporting disclosures.

  • Competitive landscape awareness: Map existing patents and publications to safeguard freedom-to-operate and adjust R&D pathways accordingly.


FAQs

1. What are the key factors determining the strength of the claims in U.S. Patent 11,819,655?
The strength hinges on claim specificity, novelty over prior art, non-obviousness, and the clarity of the inventive contribution. Well-defined, supported claims that distinguish themselves from known references are generally more robust.

2. How might prior art impact the enforceability of this patent?
Prior art that discloses similar compositions, methods, or systems can invalidate broad claims by establishing obviousness or lack of novelty, potentially leading to patent invalidation or limited enforceability.

3. Can competitors circumvent the '655 patent?
Yes. Competitors can design around the patent claims by developing alternative methods or compositions that do not infringe the claims, especially if the claims are narrowly tailored or the claims' scope is limited.

4. How can patent owners defend against invalidity challenges?
By maintaining thorough disclosure of the inventive concept, demonstrating unexpected technical advantages, and proactively considering prior art during patent prosecution, owners can bolster claim validity.

5. What future patent strategies should the patent holder consider?
Filing continuation or divisional applications to cover additional embodiments, pursuing patent term extensions, and engaging in strategic licensing can maximize the patent’s commercial and legal utility.


Sources

[1] U.S. Patent and Trademark Office. Patent Application and Grant Files.
[2] Merges, R. P., et al. (2020). Patent Law and Strategy. Oxford University Press.
[3] USPTO Patent Examination Guidelines. (latest edition).

More… ↓

⤷  Get Started Free

Details for Patent 11,819,655

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company TRULICITY dulaglutide Injection 125469 September 18, 2014 ⤷  Get Started Free 2041-12-08
Eli Lilly And Company TRULICITY dulaglutide Injection 125469 September 04, 2020 ⤷  Get Started Free 2041-12-08
Seres Therapeutics, Inc. VOWST fecal microbiota spores Capsule 125757 April 26, 2023 ⤷  Get Started Free 2041-12-08
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

International Patent Family for US Patent 11,819,655

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2018050750 ⤷  Get Started Free
United States of America 2024050732 ⤷  Get Started Free
United States of America 2022203082 ⤷  Get Started Free
United States of America 2019232042 ⤷  Get Started Free
United States of America 11224734 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.